Clinical Impact of Amyloid Positron Emission Tomography-Is It Worth the Cost?

JAMA Neurol. 2016 Dec 1;73(12):1396-1398. doi: 10.1001/jamaneurol.2016.3792.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Alzheimer Disease
  • Amyloid beta-Peptides
  • Amyloid*
  • Aniline Compounds
  • Humans
  • Positron-Emission Tomography*

Substances

  • Amyloid
  • Amyloid beta-Peptides
  • Aniline Compounds